The COVID-19 pandemic demonstrated the promise of using mRNA as medicine. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases to treat.
Academic rigor, journalistic flair
Articles on RNA therapeutics
Displaying all articles
From COVID-19 vaccines to cancer treatments and beyond, the flexibility of mRNA-based therapies gives them the potential to prevent and treat many types of diseases.
When just one of the thousands of microRNAs in people go awry, it can cause diseases ranging from heart disease to cancer.
Considered a pipe dream not too long ago, research on RNA therapeutics is progressing rapidly. Now a new manufacturing protocol will help researchers to advance the technology.
This is an era of exciting advances in medical science. But Africa is in danger of being at the back of the queue once again. What should we be doing to make sure this doesn’t happen?
Top contributors
-
Senior Specialist in Molecular Biology, Malaghan Institute of Medical Research
-
Associate Professor of Biological Sciences, Purdue University
-
Fellow, Nigerian Academy of Science
-
Associate Professor of Biology, University of Richmond
-
Assistant Professor of Biomedical Sciences, UMass Chan Medical School
